Evidence map›Paper›PMID 35153193›Full record

ReviewBMJ global health2022

COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities.

Kaymarlin Govender, Patrick Nyamaruze, Neil McKerrow, Anna Meyer-Weitz, Richard G Cowden

Open access · goldAbstract readReview
In one paragraph

Review in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kaymarlin GovenderUniversity of Kwazulu-Natal College of Law and Management Studies, Durban, South Africa govenderk2@ukzn.ac.za.ORCID 0000-0002-9586-1510
Patrick NyamaruzePsychology, University of KwaZulu-Natal College of Humanities, Durban, KwaZulu-Natal, South Africa.ORCID 0000-0003-2390-5307
Neil McKerrowMaternal, Child and Women's Health Dept, KwaZulu-Natal Department of Health, Pietermaritzburg, KwaZulu-Natal, South Africa.ORCID 0000-0001-8891-6176
Anna Meyer-WeitzPsychology, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.ORCID 0000-0002-1874-0803
Richard G CowdenHuman Flourishing Program, Harvard University, Cambridge, Massachusetts, USA.ORCID 0000-0002-9027-4253
University of KwaZulu-Natal · ZAHarvard University Press · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evolving COVID-19 pandemic is an unprecedented global public health crisis that continues to have a major impact on the African continent. Most countries within Africa are facing significant challenges vaccinating their populations for COVID-19. Inadequate COVID-19 vaccine supply, weaknesses in health system infrastructure, COVID-19 misinformation and disinformation, and ineffective health risk communication are contributing to low adult vaccination rates on the continent. Without sufficient COVID-19 vaccine coverage on the African continent, the prolonged social, economic and health impacts of this public health crisis are likely to exacerbate pre-existing social-structural issues in this part of the world. In this paper, we highlight trends in SARS-CoV-2 infections among children and adolescents (CA), compare COVID-19 vaccination patterns in Africa to those in high-income countries, and discuss some of the benefits, challenges and unknowns associated with vaccinating CA for COVID-19. In light of ongoing COVID-19 vaccine supply challenges and the slow progress that the African continent is making towards vaccinating the adult population, we suggest that the immediate priority for Africa is to accelerate COVID-19 vaccinations among adults (particularly high-risk populations) and vulnerable CA (ie, those who are immunocompromised and/or living with certain medical conditions). Accelerating the roll-out of COVID-19 vaccines and rapidly achieving high levels of vaccination coverage in the adult population will free up capacity to vaccinate CA sooner rather than later. While we hope that COVID-19 vaccines will soon become available to CA throughout Africa, countries must continue to prioritise non-pharmaceutical interventions.

Indexed as

COVID-19COVID-19 VaccinesAdolescentAdultAfricaChildHumansPandemicsSARS-CoV-2COVID-19 Vaccineschild healthCOVID-19health policypaediatricspublic health

Identifiers

PMID35153193
PMCPMC8844950
OpenAlexW4212941548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.